Two novel missense mutations of the OCTN2 gene (W283R and V446F) in a patient with primary systemic carnitine deficiency
The results of this study indicated that statins could decrease the serum levels of interleukin-enhancing binding factor 3 (ILF3) and programmed cell death ligand 1(PD-L1) in GC patients and improve their prognosis
You might know it by the brand names Ozempic or Wegovy
However, the heart rate was 3.0 beats per minute higher in the liraglutide group
Kaileras most advanced program, KAI-9531 (being developed in China as HRS9531), is an injectable dual GLP-1/GIP receptor agonist that has demonstrated positive results in clinical trials in obesity and type 2 diabetes in China
NEW YORK CITY, NY / ACCESS Newswire / July 3, 2026 / Quick disclosure before you read further: this is a paid advertorial, and this content is promotional in nature and is intended for consumer education regarding a commercially available service, not medical advice, diagnosis, or treatment